Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,641 | 13 | 99.9% |
| Food and Beverage | $13.52 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18,041 | 12 | $0 (2024) |
| ViiV Healthcare Company | $2,600 | 1 | $0 (2022) |
| AbbVie, Inc. | $13.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $850.00 | 1 | Merck Sharp & Dohme LLC ($850.00) |
| 2022 | $7,913 | 4 | Merck Sharp & Dohme LLC ($5,313) |
| 2021 | $2,125 | 1 | Merck Sharp & Dohme Corporation ($2,125) |
| 2020 | $2,338 | 1 | Merck Sharp & Dohme Corporation ($2,338) |
| 2019 | $3,825 | 3 | Merck Sharp & Dohme Corporation ($3,825) |
| 2018 | $2,550 | 1 | Merck Sharp & Dohme Corporation ($2,550) |
| 2017 | $1,054 | 3 | Merck Sharp & Dohme Corporation ($1,040) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/03/2024 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/26/2022 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/28/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: HIV | ||||||
| 01/28/2022 | Merck Sharp & Dohme LLC | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $1,062.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/06/2021 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/12/2020 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $2,338.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/24/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Consulting Fee | Cash or cash equivalent | $1,487.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/20/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/09/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $212.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/14/2018 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2017 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Neuroscience | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/30/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $520.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. Patricia Flynn, MD
Dr. Patricia Flynn, MD is a Pediatric Infectious Diseases healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609879865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patricia Flynn, MD has received a total of $20,654 in payments from pharmaceutical and medical device companies, with $850.00 received in 2024. These payments were reported across 14 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($20,641).
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Memphis, TN
- Active Since 05/23/2005
- Last Updated 07/09/2007
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1609879865
Products in Payments
- SIVEXTRO (Drug) $8,713
- ZINPLAVA (Biological) $8,288
- CABENUVA (Biological) $2,600
- NOXAFIL (Drug) $1,040
- Duopa (Drug) $13.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Infectious Diseases Doctors in Memphis
Dr. Karen Slobod, Md, MD
Pediatric Infectious Diseases — Payments: $2.2M
Octavio Ramilo, Md, MD
Pediatric Infectious Diseases — Payments: $232,026
Dr. John Devincenzo, Md, MD
Pediatric Infectious Diseases — Payments: $91,019
Dr. Elisabeth Adderson, Md, MD
Pediatric Infectious Diseases — Payments: $4,361
Isao Miyairi, M.d, M.D
Pediatric Infectious Diseases — Payments: $2,502
Dr. Elaine Tuomanen, Md, MD
Pediatric Infectious Diseases — Payments: $2,387